- Home
- AAON vs RYTM Comparison
AAON vs RYTM Comparison
Compare AAON & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAON
- RYTM
- Stock Information
- Founded
- AAON 1988
- RYTM 2008
- Country
- AAON United States
- RYTM United States
- Employees
- AAON N/A
- RYTM N/A
- Industry
- AAON Industrial Machinery/Components
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- AAON Industrials
- RYTM Health Care
- Exchange
- AAON Nasdaq
- RYTM Nasdaq
- Market Cap
- AAON 6.9B
- RYTM 6.4B
- IPO Year
- AAON N/A
- RYTM 2017
- Fundamental
- Price
- AAON $99.93
- RYTM $113.46
- Analyst Decision
- AAON Strong Buy
- RYTM Strong Buy
- Analyst Count
- AAON 5
- RYTM 13
- Target Price
- AAON $104.00
- RYTM $110.38
- AVG Volume (30 Days)
- AAON 877.2K
- RYTM 517.6K
- Earning Date
- AAON 11-06-2025
- RYTM 11-04-2025
- Dividend Yield
- AAON 0.39%
- RYTM N/A
- EPS Growth
- AAON N/A
- RYTM N/A
- EPS
- AAON 1.47
- RYTM N/A
- Revenue
- AAON $1,258,591,000.00
- RYTM $156,287,000.00
- Revenue This Year
- AAON $14.52
- RYTM $46.53
- Revenue Next Year
- AAON $12.65
- RYTM $61.83
- P/E Ratio
- AAON $70.18
- RYTM N/A
- Revenue Growth
- AAON 5.39
- RYTM 53.55
- 52 Week Low
- AAON $62.00
- RYTM $45.91
- 52 Week High
- AAON $144.07
- RYTM $115.12
- Technical
- Relative Strength Index (RSI)
- AAON 51.70
- RYTM 67.40
- Support Level
- AAON $102.34
- RYTM $105.40
- Resistance Level
- AAON $106.55
- RYTM $115.12
- Average True Range (ATR)
- AAON 4.24
- RYTM 4.13
- MACD
- AAON -0.59
- RYTM 0.48
- Stochastic Oscillator
- AAON 36.53
- RYTM 89.23
About AAON AAON Inc.
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.